R.W. McConnell & Son (Pharmacy) Limited - Accounts to registrar (filleted) - small 18.2

R.W. McConnell & Son (Pharmacy) Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.1.65 SC205011 Board of Directors Board of Directors 1.5.17 30.4.18 30.4.18 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2050112017-04-30SC2050112018-04-30SC2050112017-05-012018-04-30SC2050112016-04-30SC2050112016-05-012017-04-30SC2050112017-04-30SC205011ns15:Scotland2017-05-012018-04-30SC205011ns14:PoundSterling2017-05-012018-04-30SC205011ns10:Director12017-05-012018-04-30SC205011ns10:Director22017-05-012018-04-30SC205011ns10:PrivateLimitedCompanyLtd2017-05-012018-04-30SC205011ns10:SmallEntities2017-05-012018-04-30SC205011ns10:AuditExemptWithAccountantsReport2017-05-012018-04-30SC205011ns10:SmallCompaniesRegimeForDirectorsReport2017-05-012018-04-30SC205011ns10:SmallCompaniesRegimeForAccounts2017-05-012018-04-30SC205011ns10:FullAccounts2017-05-012018-04-30SC20501112017-05-012018-04-30SC205011ns10:Director32017-05-012018-04-30SC205011ns10:Director42017-05-012018-04-30SC205011ns10:Director52017-05-012018-04-30SC205011ns10:CompanySecretary12017-05-012018-04-30SC205011ns10:RegisteredOffice2017-05-012018-04-30SC205011ns5:CurrentFinancialInstruments2018-04-30SC205011ns5:CurrentFinancialInstruments2017-04-30SC205011ns5:ShareCapital2018-04-30SC205011ns5:ShareCapital2017-04-30SC205011ns5:RetainedEarningsAccumulatedLosses2018-04-30SC205011ns5:RetainedEarningsAccumulatedLosses2017-04-30SC205011ns5:NetGoodwill2017-05-012018-04-30SC205011ns5:IntangibleAssetsOtherThanGoodwill2017-05-012018-04-30SC205011ns5:LandBuildingsns5:OwnedOrFreeholdAssets2017-05-012018-04-30SC205011ns5:LeaseholdImprovements2017-05-012018-04-30SC205011ns5:PlantMachinery2017-05-012018-04-30SC205011ns5:FurnitureFittings2017-05-012018-04-30SC205011ns5:MotorVehicles2017-05-012018-04-30SC205011ns5:ComputerEquipment2017-05-012018-04-30SC205011ns5:NetGoodwill2017-04-30SC205011ns5:NetGoodwill2018-04-30SC205011ns5:NetGoodwill2017-04-30SC205011ns5:LandBuildings2017-04-30SC205011ns5:LeaseholdImprovements2017-04-30SC205011ns5:PlantMachinery2017-04-30SC205011ns5:LandBuildings2017-05-012018-04-30SC205011ns5:LandBuildings2018-04-30SC205011ns5:LeaseholdImprovements2018-04-30SC205011ns5:PlantMachinery2018-04-30SC205011ns5:LandBuildings2017-04-30SC205011ns5:LeaseholdImprovements2017-04-30SC205011ns5:PlantMachinery2017-04-30SC205011ns5:FurnitureFittings2017-04-30SC205011ns5:MotorVehicles2017-04-30SC205011ns5:ComputerEquipment2017-04-30SC205011ns5:FurnitureFittings2018-04-30SC205011ns5:MotorVehicles2018-04-30SC205011ns5:ComputerEquipment2018-04-30SC205011ns5:FurnitureFittings2017-04-30SC205011ns5:MotorVehicles2017-04-30SC205011ns5:ComputerEquipment2017-04-30SC205011ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-04-30SC205011ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-04-30SC205011ns5:RetainedEarningsAccumulatedLosses2017-04-30SC205011ns5:RetainedEarningsAccumulatedLosses2017-05-012018-04-30


REGISTERED NUMBER: SC205011 (Scotland)















Unaudited Financial Statements for the Year Ended 30 April 2018

for

R.W. McConnell & Son (Pharmacy) Limited

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)






Contents of the Financial Statements
for the Year Ended 30 April 2018




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Accountants' Report 9

R.W. McConnell & Son (Pharmacy) Limited

Company Information
for the Year Ended 30 April 2018







DIRECTORS: W S McConnell
Mrs U M Balls
Mrs E E McGuffie
Mrs C J R Fox
R S McConnell





SECRETARY: W S McConnell





REGISTERED OFFICE: 27 Mauchline Road
Hurlford
Ayrshire
KA1 5AB





REGISTERED NUMBER: SC205011 (Scotland)





ACCOUNTANTS: Rogerson & Goldie
Chartered Accountants
29 Portland Road
Kilmarnock
KA1 2BY

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Balance Sheet
30 April 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 4,753 6,964
Tangible assets 5 101,899 123,659
106,652 130,623

CURRENT ASSETS
Stocks 162,255 172,623
Debtors 6 354,848 349,873
Investments 7 409,072 -
Cash at bank and in hand 582,196 921,946
1,508,371 1,444,442
CREDITORS
Amounts falling due within one year 8 807,591 786,494
NET CURRENT ASSETS 700,780 657,948
TOTAL ASSETS LESS CURRENT
LIABILITIES

807,432

788,571

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 10 807,332 788,471
SHAREHOLDERS' FUNDS 807,432 788,571

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Balance Sheet - continued
30 April 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 17 December 2018 and were signed on its behalf
by:




W S McConnell - Director



Mrs U M Balls - Director


R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Notes to the Financial Statements
for the Year Ended 30 April 2018

1. STATUTORY INFORMATION

R.W. McConnell & Son (Pharmacy) Limited is a private company, limited by shares , registered in Scotland. The
company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2000, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 5% on cost
Improvements to property - 5% on cost
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33.3% on reducing balance

At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets
have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any
affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the
carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised
immediately in profit or loss.
If an impairment loss subsequently reverses, the carry amount of the asset is increased to the revised estimate of
its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss
been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit
or loss.

Government grants
Government grants in relation to tangible fixed asset are credited to profit and loss account over the useful lives
of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to
profit and loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2018

2. ACCOUNTING POLICIES - continued

Basic financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at
transaction price. Any losses arising from impairment are recognized in the profit and loss account.
Loans and borrowings are initially recognised at the transaction price including transaction costs. They are
subsequently measured at amortised cost using the effective interest rate method., less impairment. If an
arrangement constitutes a finance transaction it is measured at present value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Employee benefits
When employees have rendered service to the company, short term benefits to which the employees are entitled
are recognised at the amount expected to be paid in exchange for that service.The directors consider that no
provision is required for accrued holiday pay.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held with banks or other
short term liquid investments. Bank overdrafts, if applicable, are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 35 (2017 - 40 ) .

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2018

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2017
and 30 April 2018 44,221
AMORTISATION
At 1 May 2017 37,257
Amortisation for year 2,211
At 30 April 2018 39,468
NET BOOK VALUE
At 30 April 2018 4,753
At 30 April 2017 6,964

5. TANGIBLE FIXED ASSETS
Improvements
Freehold to Plant and
property property machinery
£    £    £   
COST
At 1 May 2017
and 30 April 2018 203,728 115,950 6,422
DEPRECIATION
At 1 May 2017 156,010 63,126 6,378
Charge for year 10,595 5,797 2
At 30 April 2018 166,605 68,923 6,380
NET BOOK VALUE
At 30 April 2018 37,123 47,027 42
At 30 April 2017 47,718 52,824 44

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2018

5. TANGIBLE FIXED ASSETS - continued

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 May 2017
and 30 April 2018 160,701 9,995 66,065 562,861
DEPRECIATION
At 1 May 2017 144,405 8,217 61,066 439,202
Charge for year 3,272 444 1,650 21,760
At 30 April 2018 147,677 8,661 62,716 460,962
NET BOOK VALUE
At 30 April 2018 13,024 1,334 3,349 101,899
At 30 April 2017 16,296 1,778 4,999 123,659

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 303,207 262,379
Other debtors 51,641 87,494
354,848 349,873

7. CURRENT ASSET INVESTMENTS
2018 2017
£    £   
Novia Investment Account 409,072 -

The Novia General Investment Account is stated at cost. Market value at April 2018 £408,844.

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade creditors 589,256 580,865
Taxation and social security 58,986 44,924
Other creditors 159,349 160,705
807,591 786,494

R.W. McConnell & Son (Pharmacy) Limited (Registered number: SC205011)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2018

9. SECURED DEBTS

The following secured debts are included within creditors:

2018 2017
£    £   

The Royal Bank of Scotland plc. holds a Bond & Floating Charge over the whole of the Company's property and
undertakings, dated 20th March, 2000.


10. RESERVES
Retained
earnings
£   

At 1 May 2017 788,471
Profit for the year 188,861
Dividends (170,000 )
At 30 April 2018 807,332

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Directors' current accounts included within Creditors due within one year are unsecured and repayable on
demand.

12. RELATED PARTY DISCLOSURES

Other than the transactions with directors as disclosed above there are no other known or undisclosed related
party transactions.

13. ULTIMATE CONTROLLING PARTY

The controlling party is Mrs U M Balls.

Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
R.W. McConnell & Son (Pharmacy) Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file
a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the
Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of R.W. McConnell & Son (Pharmacy) Limited for the year ended 30 April 2018 which comprise
the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information
and explanations you have given us.

As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.

This report is made solely to the Board of Directors of R.W. McConnell & Son (Pharmacy) Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of R.W. McConnell & Son (Pharmacy) Limited and state those matters that we have agreed to state to the Board of Directors of R.W. McConnell & Son (Pharmacy) Limited, as a body, in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that R.W. McConnell & Son (Pharmacy) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of R.W. McConnell & Son (Pharmacy) Limited. You consider that R.W. McConnell & Son (Pharmacy) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of R.W. McConnell & Son (Pharmacy) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Rogerson & Goldie
Chartered Accountants
29 Portland Road
Kilmarnock
KA1 2BY


17 December 2018